Jiacong Zhao

Jiacong Zhao

Auto-generated profile, based on publicly available information

Jiacong Zhao

Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
EDEmmanuel Enoch Dzakah
Emmanuel Enoch Dzakah
JZJiacong Zhao
Jiacong Zhao
LWLiuyan Wang
Liuyan Wang
FRFarooq Rashid
Farooq Rashid
RXRu Xu
Ru Xu
STShixing Tang
Shixing Tang
Sexually transmitted infections such as Chlamydia trachomatis can enhance HIV-1 infection. However, the molecular mechanisms modulating the enhancement of HIV-1 infectivity and replication during HIV-1/sexually transmitted infections coinfection remain elusive. In this study, we performed an ex vivo infection of HIV-1 in PBMCs of C. trachomatis‒infected patients and observed a significant increase in HIV-1 p24 levels compared with those in cells from healthy donors. Similarly, C. trachomatis‒stimulated PBMCs from healthy donors showed enhanced susceptibility to HIV-1. C. trachomatis‒stimulated CD4 T cells also harbored more HIV-1 copy numbers. RNA sequencing data revealed the upregulation of CCL3L1/CCL3L3, a paralog of CCL3 in C. trachomatis‒stimulated CD4 T cells infected with HIV-1. Furthermore, an increase in CCL3L1/CCL3L3 expression levels correlated with HIV-1 replication in C. trachomatis‒stimulated cells. However, the addition of exogenous CCL3L1 reduces HIV-1 infection of healthy cells, indicating a dual role of CCL3L1 in HIV-1 infection. Further investigation revealed that a knockout of CCL3L1/CCL3L3 in Jurkat T cells rescued the increased susceptibility of C. trachomatis‒stimulated cells to HIV-1 infection. These results reveal a role for CCL3L1/CCL3L3 in enhancing HIV-1 replication and production and highlight a mechanism for the enhanced susceptibility to HIV-1 among C. trachomatis‒infected patients.

3 June 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
JCJinfeng Cai
Jinfeng Cai
WDWei Dong
Wei Dong
PWPeipei Wang
Peipei Wang
JZJiacong Zhao
Jiacong Zhao
XLXinyu Liang
Xinyu Liang
KDKai Deng
Kai Deng
As the primary receptor for HIV-1 entry, human CD4 is widely recognized as the hallmark of HIV-1 target cells. However, viral negative factor (Nef) and viral protein U (Vpu) down-regulate surface CD4 on infected cells, raising an intriguing question: If an infected CD4 + T cell survives and establishes latency, can CD4 expression recover? By tracking the fate of HIV-1–infected CD4 + T cells, we unexpectedly found that a subset of these cells directly convert to CD8 + T cells. T cell receptor (TCR) sequencing and single-cell RNA sequencing data revealed that these induced CD8 + T cells primarily originated from regulatory CD4 + T cells, which retained a regulatory-like phenotype postconversion. Mechanistically, HIV-1 viral protein R (Vpr) specifically induced this conversion by up-regulating transforming growth factor–β1 (TGF-β1), which, in turn, activates a TGF-β–dependent signaling pathway essential for CD8 lineage reprogramming. Critically, ex vivo analyses confirmed that CD8 + T cells from both untreated and antiretroviral therapy (ART)–suppressed people living with HIV-1 (PLWH) harbor transcriptionally active viral RNA or intact proviral DNA. Furthermore, we identified that human leukocyte antigen (HLA) class II–restricted CD8 + T cells, which were present in PLWH but absent in healthy controls, share TCR clonotypes with their antigen-specific CD4 + T cell counterparts, providing direct evidence for HIV-1–driven CD4-to-CD8 conversion in vivo. Collectively, these findings uncover a viral mechanism of host-cell reprogramming, demonstrate that CD8 + T cells constitute a previously overlooked component of the HIV-1 reservoir, and broaden our understanding of latent reservoir heterogeneity, an essential consideration for future cure strategies.